Medical Equipment

Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women's Genomic Health at ISPD 2026

As a Premier Partner, Gene Solutions presented Asia-led real-world evidence from large-scale NIPT-integrated carrier screening, alongside advances in AI-enabled pregnancy-risk assessment and minimally invasive molecular approaches to women's health. SINGAPORE, July 22, 2026 /PRNewswire/ -- Gene ...

2026-07-22 11:59 3864

Haier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution Partner

Driving Digital Transformation in Blood Management for Plasma Collection Centers, Hospitals, and Blood Bank Centers KUALA LUMPUR, Malaysia, July 21, 2026 /PRNewswire/ -- Haier Biomedical (SHA: 688139) participated at the ISBT Congress 2026 in Kuala Lumpur, present...

2026-07-21 14:29 3979

Rege Nephro Secures approximately US$10.6 Million to Advance RN-014 Toward Commercialization

Financing will support development of RN-014 and RN-032 and continued expansion of the company's kidney disease pipeline KYOTO, Japan, July 21, 2026 /PRNewswire/ -- Rege Nephro Co., Ltd. ("Rege Nephro"), a clinical-stage biotechnology company focused on iPS cell-based kidney regenerative medicin...

2026-07-21 12:00 2935

Costa Rica Strengthens Engagement with South Korean and Japanese Companies to Attract New Investment

* PROCOMER carried out an investment promotion mission in both Asian markets to position Costa Rica as a strategic platform for regional operations. SAN JOSÉ, Costa Rica, July 21, 2026 /PRNewswire/ -- As part of its strategy to diversify the sources of foreign direct investment (FDI) flowing in...

2026-07-21 03:58 2952

Akeso Doses First Patient in Phase II Study of Novel TROP2/Nectin-4 Bispecific ADC (AK146D1) in Combination with Ivonescimab for Advanced NSCLC

HONG KONG, July 20, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been dosed in a Phase II clinical study (AK146D1-201) evaluating its internally developed TROP2/Nectin-4 bispecific antibody-drug conjugate (ADC), AK146D1, in combi...

2026-07-20 13:32 3544

MDT Introduces TMR1370 Ultra-Low-Power Magnetic Switch IC Enabling More Than Two Years of Standby Operation in CGM Devices

— Next-Generation TMR Magnetic Switch with Ultra-Low 50nA Maximum Supply Current Expands MDT's Proven CGM Sensor Portfolio ZHANGJIAGANG, China, July 18, 2026 /PRNewswire/ -- MultiDimension Technology

2026-07-18 08:11 6900

Getinge Interim Report April-June 2026: Good organic growth, high profitability and strong cash flow

GOTHENBURG, Sweden, July 17, 2026 /PRNewswire/ --  "We delivered a strong quarter both financially and operationally with several important key achievements," says Mattias Perjos, President and CEO of Getinge. Sales in Acute Care Therapies increased in most product categories, and the positive ...

2026-07-17 14:45 3306

The HKIC Presents Stellar Annual Report and Joins Hands with Beyond Ventures to Support World-Class Ophthalmic Healthcare Flagship Projects

"Patient Capital" Nurtures Life Science Innovations: MingMed and Super Vision Featured as Selected Investment Stories in the HKIC's Annual Report HONG KONG, July 17, 2026 /PRNewswire/ -- Beyond Ventures, a Hong Kong-based venture capital firm, warmly congratulates the Hong Kong Investment Corpora...

2026-07-17 09:14 5457

HoneyNaps Receives U.S. FDA 510(k) Clearance for SOMNUM V3.0 for AI-Based Sleep-Disordered Breathing Analysis

- FDA 510(k) Clearance (K253390) Validates AI-Based Classification of OSA, CSA, and MSA - Subtype-Specific Respiratory Event Analysis Improves Diagnostic Precision and Supports Next-Generation Digital Biomarker Development - Advanced AI Analysis Using Multi-Channel Physiological Signals, with Add...

2026-07-16 18:00 3155

POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities

GUANGZHOU, China, July 15, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled healthcare solutions and predictive healthcare capabilities, today highlighted its ongoing efforts to strengthen its health...

2026-07-15 20:00 4445

NATIONAL UNIVERSITY HOSPITAL TO EXPAND WEARABLE TECHNOLOGY FOR PATIENT MONITORING FOLLOWING SUCCESSFUL PILOT

Continuous smartwatch monitoring shown to safely support post-surgical care, reducing disruptions for patients and easing nursing time for direct patient care SINGAPORE, July 14, 2026 /PRNewswire/ -- The National University Hospital (NUH) is set to expand the use of wearable technology after a s...

2026-07-15 14:58 3666

Rayence Launches 'SHINE,' a Next-Generation X-ray Image Processing Technology for Low Dose Imaging

- Development of next-generation denoising image processing technology 'SHINE' completed; full-scale commercialization now underway - Development of 'Dynamic SHINE,' optimized for real-time C-arm fluoroscopy, also completed - SHINE is expected to help global X-ray equipment manufacturers acceler...

2026-07-14 21:00 3488

VARON Expands Pet Oxygen Solutions with New Portable Oxygen Bundle and Pet Oxygen Mask

LOS ANGELES, July 14, 2026 /PRNewswire/ -- As more pet owners look for ways to support their pets' comfort and breathing needs beyond the veterinary clinic, VARON continues to expand its pet oxygen product line with the launch of a newportable pet oxygen bundle

2026-07-14 16:50 2907

Advancing Low-Carbon Manufacturing and Global Sustainability Commitments

Report highlights clean energy, innovation and ESG recognition ZIBO, China, July 13, 2026 /PRNewswire/ -- INTCO Medical  ("the Company"), a leading global manufacturer of disposable gloves, has released its 2025 Environmental, Social and Governance (ESG) Report, ou...

2026-07-13 17:19 4705

KLN Signs MOU with Advantech and YDCare to Support Digital Transformation of Hong Kong's Healthcare System

HONG KONG, July 13, 2026 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) announced that its healthcare subsidiary, KLN Medical Limited ('KLN Medical'), has signed a tripartite Memorandum of Understanding (MOU) with Advantech Co., Ltd. ('Advantech'; Stock Code 2395.TW), a g...

2026-07-13 12:19 3368

Puncture Robotic Showcases AI-Powered Hair Restoration Innovation at WCHR 2026

SEOUL, South Korea, July 10, 2026 /PRNewswire/ -- Artificial intelligence is rapidly reshaping medical aesthetics, and hair restoration is undergoing a significant technological transformation. At the 14th World Congress for Hair Research (WCHR 2026), Puncture Robotic attracted international atte...

2026-07-10 17:47 4805

Vermon launches Vermon Group, accelerating its growth and expanding its offerings

Vermon Group opens a new chapter with the acquisition of Moduleus, the opening of TransducerWorks' new U.S. manufacturing facility, and the launch of a coordinated Group platform designed to move faster, deliver more, and stay close to customers. TOURS, France, July 8, 2026 /PRNewswire/ -- Vermo...

2026-07-08 22:02 3410

HKSH's First-in-Asia Comparative Study on Radiotherapy for Breast Cancer Reveals Hypofractionated Proton Therapy Prevents Breast Cancer Recurrence with 100% Survival Rate

Minimises Cardiopulmonary Concerns and Maintains Quality of Life HONG KONG, July 7, 2026 /PRNewswire/ -- The HKSH Cancer Centre under HKSH Medical Group (HKSH) introduced proton therapy in 2023, covering a wide range of cancer types including breast, prostate as well as head and neck cancers, an...

2026-07-07 19:27 4138

Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases

BIRMINGHAM, England, July 7, 2026 /PRNewswire/ -- Healome Therapeutics ("Healome"), a University of Birmingham spinout developing a proprietary eye-drop matrix technology for ocular surface diseases, has closed a GBP£2 million oversubscribed seed financing round led by Empirical Ventures, with p...

2026-07-07 19:07 3006

Aureka Releases OpenDDE, an Open-Source Drug Discovery Engine Designed to Accelerate AI-Driven Therapeutic Discovery

All-atom biomolecular foundation model uses co-folding as the entry point to a scalable drug discovery engine; the release marks a concrete step toward advancing open scientific AI for future biomedical research that benefit patients.  LAGUNA HILLS, Calif. and SHANGHAI, July 6, 2026 /PRNewswire/...

2026-07-07 08:00 4397
1 ... 12131415161718 ... 148